GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.

GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. As research uncovers potential benefits beyond weight loss, experts are asking whether these medications could one day be used far more widely.
Published On 25 Jul 2026
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 2 | Number of Americans taking GLP-1s for weight loss hits record high: Survey | 0 | 7 | 07-07-2026 |
| 3 | Medicare now covering some GLP-1s for $50. Here's what to know | 5 | 7 | 02-07-2026 |
| 4 | GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you're covered | 0 | 7 | 19-07-2026 |
| 5 | GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered | 0 | 7 | 18-07-2026 |
| 6 | Ozempic: Hoffnung und Grenzen des Abnehmmedikaments | 0 | 7 | 07-07-2026 |
| 7 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 8 | Medicare GLP-1 Bridge program may lead to bone problems | 0 | 5 | 07-07-2026 |
| 9 | Weight loss drugs may literally be saving people's arms and legs | 5 | 7 | 06-07-2026 |
| 10 | Obamacare rolls shrank dramatically in many states over the past year, new federal data shows | 0 | 6.77 | 06-07-2026 |